US Stock MarketDetailed Quotes
MOH Molina Healthcare
- 339.680
- +0.130+0.04%
Close May 3 16:00 ET
- 339.680
- 0.0000.00%
Post 16:44 ET
19.91BMarket Cap18.44P/E (TTM)
341.450High336.290Low374.61KVolume339.070Open339.550Pre Close127.26MTurnover0.65%Turnover Ratio18.10P/E (Static)58.60MShares423.92452wk High4.43P/B19.66BFloat Cap266.35052wk Low--Dividend TTM57.87MShs Float423.924Historical High--Div YieldTTM1.52%Amplitude10.747Historical Low339.722Avg Price1Lot Size
Molina Healthcare Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -76.64%214M | 115.01%1.66B | -225.47%-690M | 273.62%949M | 32.34%487M | 152.34%916M | -63.52%773M | -135.51%-212M | -44.90%254M | -25.35%368M |
| Net income from continuing operations | -6.23%301M | 37.75%1.09B | 285.71%216M | 6.52%245M | 24.60%309M | 24.42%321M | 20.18%792M | -45.63%56M | 60.84%230M | 34.05%248M |
| Depreciation and amortization | 2.27%45M | -2.84%171M | -8.51%43M | -6.67%42M | -4.55%42M | 10.00%44M | 34.35%176M | 34.29%47M | 40.63%45M | 41.94%44M |
| Deferred tax | 2,500.00%26M | 53.03%-31M | 106.45%2M | 23.68%-29M | 61.54%-5M | -93.75%1M | -175.00%-66M | -93.75%-31M | -153.33%-38M | -1,400.00%-13M |
| Other non cash items | -60.00%2M | -75.00%2M | -109.09%-1M | -166.67%-2M | --0 | 162.50%5M | -75.76%8M | -54.17%11M | 400.00%3M | 200.00%2M |
| Change In working capital | -137.69%-196M | 170.09%314M | -85.74%-977M | 7,433.33%660M | 73.44%111M | 2,160.87%520M | -136.63%-448M | -230.52%-526M | -103.13%-9M | -76.03%64M |
| -Change in receivables | 47.44%-123M | -718.95%-778M | -707.50%-646M | -275.00%-49M | 335.94%151M | -1,214.29%-234M | 77.11%-95M | 52.38%-80M | 150.91%28M | 31.91%-64M |
| -Change in prepaid assets | 14.29%8M | 44.35%-69M | --0 | -63.04%-75M | 96.88%-1M | 121.88%7M | -552.63%-124M | -158.33%-14M | -24.32%-46M | -455.56%-32M |
| -Change in payables and accrued expense | -115.95%-56M | 601.82%1.1B | 456.34%253M | 161.16%400M | -46.24%100M | 10.03%351M | -113.29%-220M | -136.60%-71M | -258.74%-654M | -57.04%186M |
| -Change in other working capital | -106.31%-25M | 733.33%57M | -61.77%-584M | -42.08%384M | -434.62%-139M | 238.95%396M | -550.00%-9M | -202.27%-361M | 2,171.88%663M | 67.90%-26M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -76.64%214M | 115.01%1.66B | -225.47%-690M | 273.62%949M | 32.34%487M | 152.34%916M | -63.52%773M | -135.51%-212M | -44.90%254M | -25.35%368M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -61.59%-488M | 5.82%-744M | -116.89%-25M | 19.31%-280M | 79.40%-137M | -508.11%-302M | 52.21%-790M | 127.06%148M | 50.29%-347M | -107.17%-665M |
| Net PPE purchase and sale | 15.63%-27M | 7.69%-84M | 150.00%5M | 16.13%-26M | -14.81%-31M | -39.13%-32M | -18.18%-91M | 52.38%-10M | -14.81%-31M | -107.69%-27M |
| Net business purchase and sale | ---295M | 97.76%-3M | --0 | ---- | ---- | --0 | -3.88%-134M | --0 | ---- | ---- |
| Net investment purchase and sale | 38.55%-169M | -28.35%-661M | -121.56%-36M | -66.89%-247M | 84.01%-103M | -350.00%-275M | 62.79%-515M | 150.45%167M | 77.88%-148M | -111.84%-644M |
| Net other investing changes | -40.00%3M | 108.00%4M | 166.67%6M | 88.24%-4M | -150.00%-3M | 138.46%5M | 20.63%-50M | 86.36%-9M | -1,600.00%-34M | 250.00%6M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -61.59%-488M | 5.82%-744M | -116.89%-25M | 19.31%-280M | 79.40%-137M | -508.11%-302M | 52.21%-790M | 127.06%148M | 50.29%-347M | -107.17%-665M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 4.62%-62M | 86.85%-58M | 101.64%3M | -160.00%-6M | 105.24%10M | 15.58%-65M | -140.98%-441M | -971.43%-183M | 350.00%10M | -2,828.57%-191M |
| Net issuance payments of debt | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net common stock issuance | ---- | --0 | --0 | --0 | ---- | ---- | -212.50%-400M | ---200M | --0 | ---- |
| Net other financing activities | 4.62%-62M | -41.46%-58M | -82.35%3M | -160.00%-6M | 11.11%10M | 15.58%-65M | 43.06%-41M | 325.00%17M | 350.00%10M | 28.57%9M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 4.62%-62M | 86.85%-58M | 101.64%3M | -160.00%-6M | 105.24%10M | 15.58%-65M | -140.98%-441M | -971.43%-183M | 350.00%10M | -2,828.57%-191M |
| Net cash flow | ||||||||||
| Beginning cash position | 21.25%4.91B | -10.16%4.05B | 30.85%5.62B | 13.23%4.96B | -5.53%4.6B | -10.16%4.05B | 6.70%4.51B | -3.16%4.3B | -6.37%4.38B | 8.21%4.87B |
| Current changes in cash | -161.20%-336M | 287.77%860M | -188.26%-712M | 898.80%663M | 173.77%360M | 52.50%549M | -261.84%-458M | -447.89%-247M | 65.56%-83M | -372.63%-488M |
| End cash Position | -0.54%4.57B | 21.25%4.91B | 21.25%4.91B | 30.85%5.62B | 13.23%4.96B | -5.53%4.6B | -10.16%4.05B | -10.16%4.05B | -3.16%4.3B | -6.37%4.38B |
| Free cash flow | -78.85%187M | 131.38%1.58B | -208.56%-685M | 313.90%923M | 33.72%456M | 160.00%884M | -66.60%682M | -138.54%-222M | -48.62%223M | -28.96%341M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg